Madrigal Pharmaceuticals (MDGL) Stock Highlights

317.09 | +0.93%

2024-11-21 01:11:59

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

Statistics

Range Today

310.83 323.3

Volume Today 270.95K

Range 1 Year

168.25 368.29

Volume 1 Year 110.06M

Range 3 Year

52.33 368.29

Volume 3 Year 278.16M

Range 10 Year

5.25 368.29

Volume 10 Year 509.73M

Highlights

Market Capitalization 7.65B (mid)

Floating Shares 10.73M

Current Price 317.09

Price To Earnings -14.26

Price To Revenue 89.31

Price To Book 9.84

Earnings Per Share -25.02

Payout Ratio 0%

Performance

Latest +0.93%

1 Month +48.86%

3 Months +23.65%

6 Months +43.03%

1 Year +79.86%

3 Years +280.52%

5 Years +213.11%

10 Years +192.25%

Benchmarks

Market Capitalization

36 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

332 / 368

Free Cashflow

322 / 352

Performance 5 years

47 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.